Humacyte is a biotechnology company that develops bioengineered tissues for human transplantation. The company's technology is based on a proprietary platform that uses human extracellular matrix to create tissues that are similar to native human tissues. Humacyte's lead product is a bioengineered blood vessel that is being developed for use in patients with end-stage renal disease who require hemodialysis. The company was founded in 2004 and is headquartered in Morrisville, North Carolina.